drugset / Trial / NCT01890785

Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers

NCT01890785 ↗

Phase 1 Completed 30 enrolled Shire
RandomizedCrossoverOpen-labelTreatment

Summary

Compare the pharmacokinetic profiles when the contents are emptied into a soft food and orange juice compared to the SPD489 when swallowed as an intact capsule.

Timeline

Start
2013-07-15
Primary completion
2013-08-22
Completion
2013-08-22

Outcome

Mixed primary results

paper Geometric least squares mean ratios (90% confidence intervals [CIs]) for D-amphetamine (active moiety) were within the prespecified bioequivalence range (0.80-1.25) PMID 27661399 ↗

paper ratios (90% CIs) for LDX (inactive prodrug) were below the accepted range when the contents of a 70-mg LDX capsule were mixed with orange juice PMID 27661399 ↗

paper lower 90% CI for Cmax [0.828 (0.752, 0.912)] was below the accepted range when the contents of a 70-mg LDX capsule were mixed with yogurt. PMID 27661399 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lisdexamfetamine Dimesylate Small molecule 70 mg Oral

Indications

No indication recorded.